Immunopharmacotherapy: vaccination strategies as a treatment for drug abuse and dependence.
about
Modeling of pharmacokinetics of cocaine in human reveals the feasibility for development of enzyme therapies for drugs of abuseNovel Anti-Nicotine Vaccine Using a Trimeric Coiled-Coil Hapten CarrierSuppression of Cocaine-Evoked Hyperactivity by Self-Adjuvanting and Multivalent Peptide Nanofiber VaccinesNegatively Charged Carbon Nanohorn Supported Cationic Liposome Nanoparticles: A Novel Delivery Vehicle for Anti-Nicotine Vaccine.Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the Adjuvant Finlay Proteoliposome (AFPL1)A molecular model for cocaine binding by the immunotherapeutic human/mouse chimeric monoclonal antibody 2E2.The future potential for cocaine vaccines.Pharmacological intervention of nicotine dependence.Immunogenicity of individual vaccine components in a bivalent nicotine vaccine differ according to vaccine formulation and administration conditionsA vaccine strategy that induces protective immunity against heroin.Enzyme-therapy approaches for the treatment of drug overdose and addiction.Are pharmacokinetic approaches feasible for treatment of cocaine addiction and overdose?Combined active and passive immunization against nicotine: minimizing monoclonal antibody requirements using a target antibody concentration strategyOligoclonal antibody targeting ghrelin increases energy expenditure and reduces food intake in fasted mice.Pharmacokinetic strategies for treatment of drug overdose and addiction.Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats.Developing a vaccine against multiple psychoactive targets: a case study of heroin.Enhanced attenuation of nicotine discrimination in rats by combining nicotine-specific antibodies with a nicotinic receptor antagonistAAVrh.10-mediated expression of an anti-cocaine antibody mediates persistent passive immunization that suppresses cocaine-induced behavior.Disrupted adenovirus-based vaccines against small addictive molecules circumvent anti-adenovirus immunity.Enhancing nicotine vaccine immunogenicity with liposomes.A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in ratsAAV-directed persistent expression of a gene encoding anti-nicotine antibody for smoking cessationModulating cocaine vaccine potency through hapten fluorinationTargeted polymeric therapeutic nanoparticles: design, development and clinical translationProbing active cocaine vaccination performance through catalytic and noncatalytic hapten design.Nicotine vaccines to assist with smoking cessation: current status of research.Vaccination protects rats from methamphetamine-induced impairment of behavioral responding for food.Probing the effects of hapten stability on cocaine vaccine immunogenicity.Nicotine vaccines to treat tobacco dependence.Long-acting Preparations in Substance Abuse Management: A Review and Update.Recent advances in the molecular design of synthetic vaccines.Prescreening of Nicotine Hapten Linkers in Vitro To Select Hapten-Conjugate Vaccine Candidates for Pharmacokinetic Evaluation in Vivo.Structurally distinct nicotine immunogens elicit antibodies with non-overlapping specificities.Combinatorial synthesis of nicotine analogs using an Ugi 4-CR/cyclization-reduction strategy.
P2860
Q28481567-4921C524-B39C-4A3F-B033-9D1302591C52Q28542642-9AF862B6-327E-482C-B818-3DAB42D94E66Q28833846-B054175F-EAFC-471F-84EF-0F6D033D82DDQ30361416-E3C62500-5315-4677-87A3-41A54C9384CBQ30392892-C14E8519-28C0-4CF4-9E96-DA3DE4F57F90Q33801980-3EDB61B3-E2CE-4302-AF0B-24290A5B2898Q34132804-E377B8E4-95FF-4227-A657-E5DA1C94063EQ34401794-5B8F2CF6-E021-45C6-8714-93459885F5B9Q35061547-01B623B7-C694-447D-9B64-FC81D8780C71Q35126056-E86DB8D8-3FB1-447E-B8F9-3EFAF626CABDQ35195061-051F9BDE-5B8F-4B6F-9B19-D6D03302B7EFQ35216695-9896496D-122F-44FD-A1AE-9C5EAF6F15A5Q35476326-2F968DD8-B419-4894-871C-A4B32DA255C0Q35740201-C9C79F4A-FD12-4EC1-9034-76B84635D7A6Q35813574-020B9173-9610-45BA-A33B-6965AE7E879BQ35875875-D99DB17C-58BE-4B80-876C-B0BAE9965D0BQ35892296-0B0CCA1C-6E02-47C6-83D9-165FB6B5A113Q35975765-85F6AE0A-D3D1-4B85-A208-DDC3DEB23937Q35988700-68DEE40E-53E6-470E-8228-1E39EABA8189Q36562614-CAD2D2C2-B297-4A39-BF8E-FDC4CA978CCBQ36569318-9C682C96-F89E-41C4-B610-792BEC949347Q36579253-EEC5D891-66D3-49DB-A8F4-433A5D9BF2FAQ36756701-CEA2E20A-CDC8-458B-A524-FA9B76745FB5Q36798902-B4BEE563-4211-498B-B748-A032A612EADCQ36934007-1BDCFC47-2BFA-4F9F-8152-AC52969F3C27Q36951455-A3090C4D-EDF1-46E5-973F-8818751C343FQ36987118-8576C2EF-75C0-4921-8BFE-8F57B91C5CA7Q37329852-7BB3665A-BB4D-4525-940B-2D9F586A0C54Q37624530-725CF996-6C3C-45DE-9DC5-B513B48519E0Q38056382-EFFD52B8-B157-4AE8-8138-9F603218B40FQ38119942-DEEEFB8A-D26F-4848-99E4-E72BDF7CA3D6Q38639938-38783F99-2709-4AA7-9FBD-B2CE6367277EQ38850703-9C6020EB-C0E9-4D62-A700-5511C2AB3DA3Q40431126-9D541B7D-4ACD-4898-B7E4-4CF0753117B8Q51064862-6D1153CF-7DDC-44E0-8625-6C72C27DF849
P2860
Immunopharmacotherapy: vaccination strategies as a treatment for drug abuse and dependence.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunopharmacotherapy: vaccina ...... for drug abuse and dependence.
@en
Immunopharmacotherapy: vaccina ...... for drug abuse and dependence.
@nl
type
label
Immunopharmacotherapy: vaccina ...... for drug abuse and dependence.
@en
Immunopharmacotherapy: vaccina ...... for drug abuse and dependence.
@nl
prefLabel
Immunopharmacotherapy: vaccina ...... for drug abuse and dependence.
@en
Immunopharmacotherapy: vaccina ...... for drug abuse and dependence.
@nl
P2860
P1476
Immunopharmacotherapy: vaccina ...... for drug abuse and dependence.
@en
P2093
Amira Y Moreno
Kim D Janda
P2860
P304
P356
10.1016/J.PBB.2009.01.015
P407
P577
2009-04-01T00:00:00Z